VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $7,400,000 | +46.0% | 318,400 | 0.0% | 3.25% | +41.8% |
| Q1 2018 | $5,069,000 | -1.0% | 318,400 | +29.2% | 2.29% | -12.6% |
| Q4 2017 | $5,122,000 | +61.4% | 246,500 | +11.3% | 2.62% | +48.2% |
| Q3 2017 | $3,174,000 | -2.7% | 221,500 | +17.5% | 1.77% | -14.2% |
| Q2 2017 | $3,261,000 | +90.4% | 188,500 | +21.4% | 2.06% | +93.3% |
| Q1 2017 | $1,713,000 | -24.0% | 155,300 | 0.0% | 1.07% | -31.0% |
| Q4 2016 | $2,255,000 | -12.8% | 155,300 | +47.5% | 1.55% | -24.3% |
| Q3 2016 | $2,585,000 | +122.1% | 105,300 | +82.2% | 2.04% | +74.2% |
| Q2 2016 | $1,164,000 | -23.4% | 57,800 | 0.0% | 1.17% | -18.7% |
| Q1 2016 | $1,520,000 | -61.6% | 57,800 | +48.6% | 1.44% | -62.1% |
| Q4 2015 | $3,954,000 | – | 38,900 | – | 3.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |